ArticleRwanda journal of medicine and health sciences2024
Prevalence of Metabolic Syndrome and Its Determinants in Pregnant Women in Auchi, Edo State, Nigeria.
Article in Rwanda journal of medicine and health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There are limited epidemiological data on metabolic syndrome (MetS) during gestation in many developing nations. Available information on MetS prevalence in pregnancy is of clinical importance as it could aid in identifying pregnant women at risk of adverse perinatal outcomes. This study was designed to determine the prevalence of MetS, and its associated risk factors in pregnant women in Auchi, Edo Stage, Nigeria. Methods: This hospital-based cross-sectional study involved 223 pregnant women aged 17-45 years recruited from selected hospitals in Auchi and its environs. Information on socio-demography and nutritional habits were obtained using a self-administered questionnaire. Anthropometric indices were determined using appropriate methods for height, weight and BMI. Blood glucose, triglyceride, high-density lipoprotein, low-density lipoprotein and total cholesterol were determined from the serum of the study participants using enzymatic assay. The prevalence of MetS was determined using the HNLBI/AHA and NECP ATP III definitions, modified for pregnant women. Results: The findings revealed the following prevalences: MetS 10.8%, low HDL 35.7%, obesity 14.4%, high blood pressure 4.5%, hyperglycaemia 21.6% and hypertriglyceridemia 11.8%. There was no significant association between social-demographic and life style parameters with MetS. Conclusion: The findings emphasize the importance of vigilant monitoring of pregnant women to reduce the risk of metabolic syndrome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.